158 related articles for article (PubMed ID: 26873173)
1. Insights on N-glycosylation of human haptoglobin and its association with cancers.
Zhang S; Shang S; Li W; Qin X; Liu Y
Glycobiology; 2016 Jul; 26(7):684-692. PubMed ID: 26873173
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
Zhang S; Jiang K; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
[TBL] [Abstract][Full Text] [Related]
3. Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.
Shu H; Zhang S; Kang X; Li S; Qin X; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):528-34. PubMed ID: 21606158
[TBL] [Abstract][Full Text] [Related]
4. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
5. In-depth investigation of altered glycosylation in human haptoglobin associated cancer by mass spectrometry.
Oh MJ; Lee SH; Kim U; An HJ
Mass Spectrom Rev; 2023 Mar; 42(2):496-518. PubMed ID: 34037272
[TBL] [Abstract][Full Text] [Related]
6. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.
Zhu J; Wu J; Yin H; Marrero J; Lubman DM
J Proteome Res; 2015 Nov; 14(11):4932-9. PubMed ID: 26448449
[TBL] [Abstract][Full Text] [Related]
7. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
Mondal G; Saroha A; Bose PP; Chatterjee BP
Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
[TBL] [Abstract][Full Text] [Related]
8. ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.
Shang S; Qin X; Li W; Zhang S; Liu Y
Discov Med; 2016 Jan; 21(113):15-23. PubMed ID: 26896598
[TBL] [Abstract][Full Text] [Related]
9. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
10. Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.
Pompach P; Brnakova Z; Sanda M; Wu J; Edwards N; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1281-93. PubMed ID: 23389049
[TBL] [Abstract][Full Text] [Related]
11. Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells.
Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Nakagawa T; Matsumoto H; Asahi M; Koyama N; Miyoshi E
Biochem Biophys Res Commun; 2008 Dec; 377(3):792-6. PubMed ID: 18951869
[TBL] [Abstract][Full Text] [Related]
12. GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness.
Jiang K; Li W; Zhang Q; Yan G; Guo K; Zhang S; Liu Y
Oncotarget; 2016 Apr; 7(17):23530-41. PubMed ID: 26993603
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
14. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry.
Ji ES; Hwang H; Park GW; Lee JY; Lee HK; Choi NY; Jeong HK; Kim KH; Kim JY; Lee S; Ahn YH; Yoo JS
Anal Bioanal Chem; 2016 Nov; 408(27):7761-7774. PubMed ID: 27565792
[TBL] [Abstract][Full Text] [Related]
15. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
[TBL] [Abstract][Full Text] [Related]
16. α1-3/4 fucosylation at Asn 241 of β-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers.
Park SY; Lee SH; Kawasaki N; Itoh S; Kang K; Hee Ryu S; Hashii N; Kim JM; Kim JY; Hoe Kim J
Int J Cancer; 2012 May; 130(10):2366-76. PubMed ID: 21780104
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation of serum haptoglobin as a marker of gastric cancer: an overview for clinicians.
Jeong S; Oh MJ; Kim U; Lee J; Kim JH; An HJ
Expert Rev Proteomics; 2020 Feb; 17(2):109-117. PubMed ID: 32149536
[No Abstract] [Full Text] [Related]
18. Expression of haptoglobin receptors in human hepatoma cells.
Okuda M; Tokunaga R; Taketani S
Biochim Biophys Acta; 1992 Aug; 1136(2):143-9. PubMed ID: 1354488
[TBL] [Abstract][Full Text] [Related]
19. Identification of unique glycoisoforms of vitamin D-binding protein and haptoglobin as biomarker candidates in hepatocarcinogenesis of STAM mice.
Yoshida Y; Furukawa JI; Naito S; Higashino K; Numata Y; Shinohara Y
Glycoconj J; 2018 Oct; 35(5):467-476. PubMed ID: 30194503
[TBL] [Abstract][Full Text] [Related]
20. Protein glycosylation in viral hepatitis-related HCC: Characterization of heterogeneity, biological roles, and clinical implications.
Zhang S; Cao X; Gao Q; Liu Y
Cancer Lett; 2017 Oct; 406():64-70. PubMed ID: 28789967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
